Two sizable companies and a handful of small Asian issuers were listed in the US this past week. Read more here.
FDA clears United Therapeutics for human trials of pig-to-human kidney transplants. Trial involves gene-edited pig kidneys ...
Zacks.com on MSN17h
UTHR or ZTS: Which Is the Better Value Stock Right Now?Investors with an interest in Medical - Drugs stocks have likely encountered both United Therapeutics (UTHR) and Zoetis (ZTS). But which of these two stocks offers value investors a better bang for ...
Gain’s lead program in Parkinson’s disease has been awarded funding support from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The Silverstein Foundation for Parkinson’s with GBA, ...
United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...
Hosted on MSN2d
L3Harris’s Viper Shield EW suite completes first flightL3Harris Technologies' Viper Shield electronic warfare suite has completed its first flight aboard the US Air Force’s (USAF) ...
UBS lowered the firm’s price target on United Therapeutics (UTHR) to $460 from $475 and keeps a Buy rating on the shares. United Therapeutics ...
Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.
Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their ...
Orchard Therapeutics, a Kyowa Kirin company, today announced presentations from seven abstracts from across its hematopoietic stem cell (HSC) gene therapy portfolio will be featured at the 21st Annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback